Katie Sullivan Taulane

Katie Sullivan Taulane has a significant amount of work experience in the pharmaceutical industry. Katie is currently working as an Associate Director of Key Customer Strategy & Marketing at Servier Pharmaceuticals. Prior to this, they worked at Servier / Agios Pharmaceuticals as a Senior Hematology Consultant, where they played a key role in launching first-in-class IDH1 & IDH2 inhibitors and educating key opinion leaders, cancer centers, and teaching institutions about these new therapies. Katie also held the position of Hematology Clinical Account Specialist at Pharmacyclics, where they successfully launched and promoted the first-in-class oral BTK-inhibitor to hematologists/oncologists and gained expertise in advocacy and market access. Before that, they worked as a Hematology Oncology Consultant at Celgene, promoting Vidaza and Revlimid, and as an Executive Health Care Solutions Specialist at Centocor Ortho Biotech, where they promoted Procrit and Doxil. Katie has extensive knowledge of specialty pharmacy products, limited distribution networks, and in-office dispensing practices.

Katie Sullivan Taulane received a Bachelor of Applied Science (B.A.Sc.) degree in Business Administration and Management, General from Arizona State University. Katie studied at the university from 1992 to 1996.